JPRN-UMIN000004678Completed未知
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetes - Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetes
Keio University , School of Mecidicine, Department of Internal Medicine0 sites50 target enrollmentStarted: January 1, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Type 1 diabetes mellitus 2.Impaired renal function [serum-creatinine; =>1.5mg/dL(male), =>1.3mg/dL(female) or eGFR<30mL/min] 3.Severe liver dysfunction [AST, ALT=>3 fold above ULN] 4.Patients who are disqualified from the study by investigator for any reasons.
Investigators
Similar Trials
Completed
Not Applicable
A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in KanagawaType 2 diabetesJPRN-UMIN000014382Diabetes Committee, Kanagawa Physicians Association860
Completed
Not Applicable
The efficacy and the safety of the DPP4 inhibitor in patients with type 2 diabetes complicated with renal dysfunctiodiabetes mellitusJPRN-UMIN000030172Osaka Saiseikai Noe Hospital400
Completed
Not Applicable
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
Completed
Not Applicable
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseJPRN-UMIN000018464ihon University School of Medicine100
Recruiting
Not Applicable
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000009493ihon University School of Medicine30